Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Keratosis, Actinic 11Breast Neoplasms 3Pain 2Non-melanoma Skin Cancer 2Lymphoma, Follicular 2Acute Pain 2Skin Neoplasms 1Photosensitivity Disorders 1Pain, Postoperative 1Neurofibromatosis 1 1Neoplasms 1Hand-Foot Syndrome 1Carcinoma, Basal Cell 1

Interventions

Ketamine 2Gabapentin 2Diclofenac 2Anesthesia, General 2Acetaminophen 2Tea 1Quality of Life 1Pregabalin 1Passive Cutaneous Anaphylaxis 1Oxycodone 1Minocycline 1Meloxicam 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1Hydromorphone 1Ethyl Chloride 1Epinephrine 1Duloxetine Hydrochloride 1Diathermy 1Dexmedetomidine 1Cryotherapy 1Bupivacaine 1Anti-Inflammatory Agents, Non-Steroidal 1Analgesia, Patient-Controlled 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Acute Pain × Diclofenac × Clear all
NCT01982539 2020-05-07

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Depomed

Phase 4 Completed
25 enrolled 8 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

NCT02287350 2017-07-11

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Depomed

Phase 4 Completed
51 enrolled 45 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡